Scinai Immunotherapeutics (SCNI) Change in Account Payables (2019 - 2026)
Scinai Immunotherapeutics (SCNI) posted Change in Account Payables of $199000.0 for Q1 2026, up 74.56% sequentially from $114000.0 in Q2 2025, and up 17.75% YoY from $169000.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Change in Account Payables (2019 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Change in Account Payables for 8 years, with the latest figure at $199000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 17.75% year-over-year to $199000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $741000.0 (up 4258.82% YoY) and the FY2025 annual result came in at -$157000.0, down 200.0% from the prior year.
- Change in Account Payables advanced to $199000.0 in Q1 2026 per SCNI's latest filing, from $114000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $630000.0 in Q4 2022 and troughed at -$748000.0 in Q2 2022.
- A 5-year average of $40466.7 and a median of $116000.0 in 2022 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 378.46% in 2022, down 236.0% in 2022.
- Over 5 years, Change in Account Payables stood at $630000.0 in 2022, then plunged by 132.7% to -$206000.0 in 2023, then surged by 225.73% to $259000.0 in 2024, then sank by 55.98% to $114000.0 in 2025, then surged by 74.56% to $199000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $199000.0, $114000.0, and $169000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | 348,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199,000.00 |
| Mar 31, 2026 | 199,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Sep 30, 2024 | -227,000.00 |
| Sep 30, 2024 | -227,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Dec 31, 2023 | -206,000.00 |
| Dec 31, 2023 | -206,000.00 |
| Sep 30, 2023 | -104,000.00 |
| Sep 30, 2023 | -104,000.00 |
| Jun 30, 2023 | -660,000.00 |
| Jun 30, 2023 | -660,000.00 |